Abstract:Background According to prescribing information for Myrtol standardized enteric-coated soft capsules, the medicine should be taken on an empty stomach. Some patients may experience stomach discomfort after oral administration in fasted state and would prefer to take the medicine after a meal. However, there is no literature addressing the effect of meal on absorption of this drug; therefore, it is desirable to explore the feasibility of taking the capsule after a meal from pharmacokinetic perspective. Methods A gas chromatography coupled with triple quadruples mass spectrometry assay was established and validated for determining plasma concentrations of eucalyptol, a target component of Myrtol standardized capsules. A self-control clinical study was carried out in healthy male volunteers in fasted and fed states after a single oral dose of 300 mg capsules. Comparison of pharmacokinetic parameters in the two phases and bioequivalence evaluation were performed. Results The specificity, sensitivity, accuracy, and precision of the assay satisfied the requirements for biopharmaceutical analysis. Pharmacokinetic parameters of eucalyptol (fasted vs fed) were as follows: maximal plasma concentrations (Cmax) (167.60±114.69 vs 518.89±314.47 ng·mL−1), time of maximum concentration (Tmax) (3.7±1.1 vs 4.8±0.7 h), elimination half-life (T1/2) (3.2±1.4 vs 2.6±0.7 h), area under the plasma concentration–time curve (AUC0–t) (584.91±369.90 vs 1,271.61±605.82 ng·h·mL−1), and AUC0–∞ (690.36±467.26 vs 1,458.02±720.21 ng·h·mL−1). There was statistically significant difference in Cmax, AUC0–t, and AUC0–∞ between the two dosing methods (P<0.05). Pharmacokinetic parameters of eucalyptol given in fasted state in Chinese were comparable to those in Germany population. The 90% confidence intervals for the ratio of Cmax (18.4%~64.7%), AUC0–t (28.9%~68.5%), and AUC0–∞ (31.1%~68.4%) values for the test (fasted) and reference (fed) were beyond the Food and Drug Administration’s acceptable range of 80%~125%. In addition, significant difference was obtained in Tmax (P<0.05). Conclusion Compared with dosing at fasted state, taking Myrtol standardized capsules after a meal achieves a delayed absorption rate and an increased absorption extent. The two dosing methods were not bioequivalent in this small study and, thus, not interchangeable. Patient preference and pharmacokinetic food–drug interaction issue should be balanced. Further clinical study is necessary to explore the clinical outcome of oral administration of Myrtol standardized capsules after or with meal.

Pharmacokinetics of Matrine Capsules in Healthy Volunteers

Is It Appropriate Regarding Patient Preference to Take Myrtol Standardized Enteric-Coated Soft Capsules after a Meal Rather Than at Fasted State? A Food–drug Pharmacokinetic Interaction Study in Healthy Chinese Volunteers

Matrine Determination and Pharmacokinetics in Human Plasma Using LC/MS/MS.

Effects of Matrine and Oxymatrine on Catalytic Activity of Cytochrome P450s in Rats.

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

Toxic Markers of Matrine Determined Using (1) H-NMR-Based Metabolomics in Cultured Cells In Vitro and Rats In Vivo.

Toxic Markers Of Matrine Determined Using H-1-Nmr-Based Metabolomics In Cultured Cells In Vitro And Rats In Vivo

Pharmacokinetics of Butylphathlide Capsule in Chinese Healthy Volunteers

Pharmacokinetics of Trimetazidines Tablets in Chinese Healthy Volunteers

A Systematic Review of the Pharmacology, Toxicology and Pharmacokinetics of Matrine

Gas chromatography-mass spectrometry determination of matrine in human plasma

Pharmacokinetics of the Material Basis Compounds of Tianshu Capsule in Treating Migraine

Bioequivalence evaluation of domestic tablets and imported capsules of rivastigmine tartrate

The Pharmacokinetics Sdudy of Modafinil Acid in Plasma of Healthy Volunteers

Tolerability and Pharmacokinetics of Tratinterol Hydrochloride Tablets in Healthy Subjects after a Single Dose Administration

Evaluation of Bioequivalence of Mirtazapine Tablets

Effect of a high‐fat meal on the relative bioavailability of HMPL‐689 in Chinese Healthy Volunteers

Pharmacokinetics of Tramadol Hydrochloride-Paracetamol Tablets in Chinese Healthy Volunteers

A Phase I Study for Evaluating the Safety and Tolerability of Zhishenjieyu Capsule

[Pharmacokinetic Comparison Between Tanreqing Capsules Substitute and Tanreqing Capsules in Rats by LC-MS/MS].

Bioequivalence of trimetazidine dihydrochloride tablets in Chinese healthy subjects